🏛 Organisation

Stanford University

1 story First seen Jul 19, 2026 Latest Jul 19, 2026

🧬 AI profile — grown from 6ic coverage Stanford University is a private research university located in Stanford, California. The university's medical research division, in collaboration with other institutions, has been involved in studying the effects of fluvoxamine in treating long COVID symptoms, including fatigue. This research aims to identify potential treatments for long COVID patients.

Coverage by desk

Science 1

Coverage · last 14 days

Jul 7Jul 20

Recurring themes

long COVID ×1 fluvoxamine ×1 McMaster University ×1 Brazil ×1 clinical trial ×1

🕸 Connection map 🌌 Full galaxy →

Connected entities

SARS-CoV-2 ×1 COVID ×1 University of British Columbia ×1 REVIVE-TOGETHER ×1 Fluvoxamine ×1 Brazilian ×1 Brazil ×1 Metformin ×1 McMaster University ×1

Every story (1)

Breakthrough in Long COVID Treatment: Fluvoxamine Shows Promise in Reducing Fatigue

Science · Jul 19, 2026 · BlockchainSpace AI